The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Cited by
Sanuki, N., Takeda, A., Oku, Y., Mizuno, T., Aoki, Y., Eriguchi, T., Iwabuchi, S., & Kunieda, E. (2014) · Acta Oncologica · doi:10.3109/0284186x.2013.820342 · Cited by 260
Metadata
- Authors
- Cárdenes, H. R., Price, T. R., Perkins, S. M., Maluccio, M., Kwo, P., Breen, T. E., Henderson, M. A., Schefter, T. E., Tudor, K., Deluca, J., & Johnstone, P. A. S.
- Venue
- Clinical and Translational Oncology
- Published
- 2010-03
- Volume
- 12
- Issue
- 3
- Pages
- 218-225
- ISSN
- 1699-048X (ISSN-L)
- 1699-3055
- OpenAlex
- W2144284656
- Cited by
- 307
- References
- 3
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. https://app.cochat.ai/papers/10.1007/s12094-010-0492-x
- The paper
- Cárdenes, H. R., Price, T. R., Perkins, S. M., Maluccio, M., Kwo, P., Breen, T. E., Henderson, M. A., Schefter, T. E., Tudor, K., Deluca, J., & Johnstone, P. A. S. (2010). Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-010-0492-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
